AI Verdict
JNJ has stronger fundamentals based on our AI analysis.
ABT vs JNJ Fundamental Comparison
| Metric | ABT | JNJ |
|---|---|---|
| Revenue | $44.3B | $94.2B |
| Net Income | $6.5B | $26.8B |
| Net Margin | 14.7% | 28.5% |
| ROE | 12.5% | 32.9% |
| ROA | 7.5% | 13.5% |
| Current Ratio | 1.58x | 1.03x |
| Debt/Equity | 0.25x | 0.51x |
| EPS | $3.72 | $11.03 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs JNJ: Frequently Asked Questions
Is ABT or JNJ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JNJ has stronger fundamentals. ABT is rated BUY (77% confidence) while JNJ is rated BUY (86% confidence). This is not investment advice.
How does ABT compare to JNJ fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs JOHNSON & JOHNSON's 32.9%. Net margins are 14.7% vs 28.5% respectively.
Which stock pays higher dividends, ABT or JNJ?
ABT has a dividend yield of N/A or no dividend while JNJ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or JNJ for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while JNJ has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs JNJ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs JNJ, the AI consensus favors JNJ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.